{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T16:57:51Z","timestamp":1765040271592},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,9,7]],"date-time":"2010-09-07T00:00:00Z","timestamp":1283817600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1007\/s11060-010-0385-4","type":"journal-article","created":{"date-parts":[[2010,9,6]],"date-time":"2010-09-06T19:00:54Z","timestamp":1283799654000},"page":"239-245","source":"Crossref","is-referenced-by-count":19,"title":["Podoplanin and CD34 in peripheral nerve sheath tumours: focus on neurofibromatosis 1-associated atypical neurofibroma"],"prefix":"10.1007","volume":"103","author":[{"given":"Urs","family":"Naber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhard E.","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Glatzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor Felix","family":"Mautner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Hagel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,9,7]]},"reference":[{"key":"385_CR1","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.1242\/jcs.037507","volume":"121","author":"JS Nielsen","year":"2008","unstructured":"Nielsen JS, McNagny KM (2008) Novel functions of the CD34 family. J Cell Sci 121:3683\u20133692","journal-title":"J Cell Sci"},{"key":"385_CR2","first-page":"2997","volume":"28","author":"M Raica","year":"2008","unstructured":"Raica M, Cimpean AM, Ribatti D (2008) The role of podoplanin in tumor progression and metastasis. Anticancer Res 28:2997\u20133006","journal-title":"Anticancer Res"},{"key":"385_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.bjc.6603518","volume":"96","author":"A Wicki","year":"2007","unstructured":"Wicki A, Christofori G (2007) The potential role of podoplanin in tumour invasion. Br J Cancer 96:1\u20135","journal-title":"Br J Cancer"},{"key":"385_CR4","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.stem.2007.07.008","volume":"1","author":"B Hegedus","year":"2007","unstructured":"Hegedus B, Dasgupta B, Shin JE et al (2007) Neurofibromatosis-1 regulates neuronal and glial cell differentiation from neuroglial progenitors in vivo by both cAMP- and Ras-dependent mechanisms. Cell Stem Cell 1:443\u2013457","journal-title":"Cell Stem Cell"},{"key":"385_CR5","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s003810050398","volume":"15","author":"M Ruggieri","year":"1999","unstructured":"Ruggieri M (1999) The different forms of neurofibromatosis. A review. Childs Nerv Syst 15:295\u2013308","journal-title":"Childs Nerv Syst"},{"key":"385_CR6","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0092-8674(90)90024-9","volume":"62","author":"G Xu","year":"1990","unstructured":"Xu G, O\u2019Connell P, Viskochil D et al (1990) The Neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62:599\u2013608","journal-title":"Cell"},{"key":"385_CR7","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/jmg.39.5.311","volume":"39","author":"DG Evans","year":"2002","unstructured":"Evans DG, Baser ME, McGaughran J, Sharif S, Howard E, Moran A (2002) Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet 39:311\u2013314","journal-title":"J Med Genet"},{"key":"385_CR8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11060-006-9266-2","volume":"82","author":"C Hagel","year":"2007","unstructured":"Hagel C, Zils U, Peiper M et al (2007) Histopathology and clinical outcome of NF1-associated sporadic malignant peripheral nerve sheath tumors. J Neurooncol 82:187\u2013192","journal-title":"J Neurooncol"},{"key":"385_CR9","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/cncr.22533","volume":"109","author":"A Ferrari","year":"2007","unstructured":"Ferrari A, Bisogno G, Macaluso A et al (2007) Soft-tissue sarcomas in children and adolescents with neurofibromatosis type 1. Cancer 109:1406\u20131412","journal-title":"Cancer"},{"key":"385_CR10","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1128\/MCB.01392-08","volume":"29","author":"SS Houshmandi","year":"2009","unstructured":"Houshmandi SS, Emnett RJ, Giovannini M, Gutmann DH (2009) The neurofibromatosis 2 protein, Merlin, regulates glial cell growth in an ErbB2- and Src-dependent manner. Mol Cell Biol 29:1472\u20131486","journal-title":"Mol Cell Biol"},{"key":"385_CR11","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0092-8674(93)90406-G","volume":"72","author":"JA Trofatter","year":"1993","unstructured":"Trofatter JA, MacCollin MM (1993) A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72:791\u2013800","journal-title":"Cell"},{"key":"385_CR12","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1399-0004.2008.01060.x","volume":"74","author":"C Boyd","year":"2008","unstructured":"Boyd C, Smith MJ, Kluwe L, Balogh A, MacCollin M, Plotkin SR (2008) Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosis. Clin Genet 74:358\u2013366","journal-title":"Clin Genet"},{"key":"385_CR13","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1212\/01.WNL.0000163982.78900.AD","volume":"64","author":"M MacCollin","year":"2005","unstructured":"MacCollin M, Chiocca EA, Evans DG et al (2005) Diagnostic criteria for schwannomatosis. Neurology 64:1838\u20131845","journal-title":"Neurology"},{"key":"385_CR14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/jama.278.1.51","volume":"278","author":"DH Gutmann","year":"1997","unstructured":"Gutmann DH, Aylsworth A, Carey JC et al (1997) The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 278:51\u201357","journal-title":"JAMA"},{"key":"385_CR15","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/archneur.1988.00520290115023","volume":"45","author":"DA Stumpf","year":"1988","unstructured":"Stumpf DA, Alksne JF, Annegers JF (1988) Neurofibromatosis NIH consensus development conference statement. Arch Neurol 45:575\u2013578","journal-title":"Arch Neurol"},{"key":"385_CR16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00019052-200302000-00004","volume":"16","author":"ME Baser","year":"2003","unstructured":"Baser ME, Evans DGR, Gutmann DH (2003) Neurofibromatosis 2. Curr Opin Neurol 16:27\u201333","journal-title":"Curr Opin Neurol"},{"key":"385_CR17","first-page":"156","volume-title":"WHO Classification of tumours of the central nervous system","author":"BW Scheithauer","year":"2007","unstructured":"Scheithauer BW, Louis DN, Hunter S, Woodruff JM, Antonescu CR (2007) Neurofibroma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) WHO Classification of tumours of the central nervous system. International Agency for Research on Cancer, Lyon, pp 156\u2013157"},{"key":"385_CR18","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1309\/M7D5KTVYYE51XYQA","volume":"129","author":"CH Jokinen","year":"2008","unstructured":"Jokinen CH, Dadras SS, Goldblum JR, van de Rijn M, West RB, Rubin BP (2008) Diagnostic implications of podoplanin expression in peripheral nerve sheath neoplasms. Am J Clin Pathol 129:886\u2013893","journal-title":"Am J Clin Pathol"},{"key":"385_CR19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.immuni.2004.11.014","volume":"22","author":"E Drew","year":"2005","unstructured":"Drew E, Merzaban JS, Seo W, Ziltener HJ, McNagny KM (2005) CD34 and CD43 inhibit mast cell adhesion and are required for optimal mast cell reconstitution. Immunity 22:43\u201357","journal-title":"Immunity"},{"key":"385_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V87.1.1.1","volume":"87","author":"DS Krause","year":"1996","unstructured":"Krause DS, Fackler MJ, Civin CI, May WS (1996) CD34: structure, biology, and clinical utility. Blood 87:1\u201313","journal-title":"Blood"},{"key":"385_CR21","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1182\/blood-2006-11-059394","volume":"110","author":"JS Nielsen","year":"2007","unstructured":"Nielsen JS, McNagny KM (2007) Influence of host irradiation on long-term engraftment by CD34-deficient hematopoietic stem cells. Blood 110:1076\u20131077","journal-title":"Blood"},{"key":"385_CR22","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1084\/jem.169.5.1721","volume":"169","author":"RG Andrews","year":"1989","unstructured":"Andrews RG, Singer JW, Bernstein ID (1989) Precursors of colony-forming cells in humans can be distinguished from colony-forming cells by expression of the CD33 and CD34 antigens and light scatter properties. J Exp Med 169:1721\u20131731","journal-title":"J Exp Med"},{"key":"385_CR23","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1172\/JCI113409","volume":"81","author":"RJ Berenson","year":"1988","unstructured":"Berenson RJ, Andrews RG, Bensinger WI et al (1988) Antigen CD34+\u00a0marrow cells engraft lethally irradiated baboons. J Clin Invest 81:951\u2013955","journal-title":"J Clin Invest"},{"key":"385_CR24","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1182\/blood.V75.10.1941.1941","volume":"75","author":"H Ema","year":"1990","unstructured":"Ema H, Suda T, Miura Y, Nakauchi H (1990) Colony formation of clone-sorted human hematopoietic progenitors. Blood 75:1941\u20131946","journal-title":"Blood"},{"key":"385_CR25","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1182\/blood.V75.12.2417.2417","volume":"75","author":"L Fina","year":"1990","unstructured":"Fina L, Molgaard HV, Robertson D et al (1990) Expression of the CD34 gene in vascular endothelial cells. Blood 75:2417\u20132426","journal-title":"Blood"},{"key":"385_CR26","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1182\/blood.V85.1.96.bloodjournal85196","volume":"85","author":"PE Young","year":"1995","unstructured":"Young PE, Baumhueter S, Lasky LA (1995) The sialomucin CD34 is expressed onhematopoietic cells and blood vessels during murine development. Blood 85:96\u2013105","journal-title":"Blood"},{"key":"385_CR27","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1309\/C7N9-J2AU-5TB9-5FRL","volume":"114","author":"MA Khalifa","year":"2000","unstructured":"Khalifa MA, Montgomery EA, Ismiil N, Azumi N (2000) What are the CD34+\u00a0cells in benign peripheral nerve sheath tumors? Double immunostaining study of CD34 and S-100 protein. Am J Clin Pathol 114:123\u2013126","journal-title":"Am J Clin Pathol"},{"key":"385_CR28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1600-0560.2008.01212.x","volume":"36","author":"JC Tard\u00edo","year":"2009","unstructured":"Tard\u00edo JC (2009) CD34-reactive tumors of the skin An updated review of an ever-growing list of lesions. J Cutan Pathol 36:89\u2013102","journal-title":"J Cutan Pathol"},{"key":"385_CR29","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1097\/00000478-199310000-00009","volume":"17","author":"SW Weiss","year":"1993","unstructured":"Weiss SW, Nickoloff BJ (1993) CD34 is expressed by a distinctive cell population in peripheral nerve, nerve sheath tumors, and related lesions. Am J Surg Pathol 17:1039\u20131045","journal-title":"Am J Surg Pathol"},{"key":"385_CR30","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/PAP.0b013e3181915e94","volume":"16","author":"AN Kalof","year":"2009","unstructured":"Kalof AN, Cooper K (2009) D2\u201340 immunohistochemistry\u2014so far! Adv Anat Pathol 16:62\u201364","journal-title":"Adv Anat Pathol"},{"key":"385_CR31","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s00428-006-0223-4","volume":"449","author":"SB Sonne","year":"2006","unstructured":"Sonne SB, Herlihy AS, Hoei-Hansen CE et al (2006) Identity of M2A (D2\u201340) antigen and gp36 (Aggrus, T1\u03b1-2, podoplanin) in human developing testis, testicular carcinoma in situ and germ-cell tumours. Virchows Arch 449:200\u2013206","journal-title":"Virchows Arch"},{"key":"385_CR32","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/modpathol.3800259","volume":"18","author":"AY Chu","year":"2005","unstructured":"Chu AY, Litzky LA, Pasha TL, Acs G, Zhang PJ (2005) Utility of D2\u201340, a novel mesothelial marker, in the diagnosis of malignant mesothelioma. Mod Pathol 18:105\u2013110","journal-title":"Mod Pathol"},{"key":"385_CR33","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/ijc.20656","volume":"113","author":"E Martin-Villar","year":"2005","unstructured":"Martin-Villar E, Scholl FG, Gamallo C et al (2005) Characterization of human PA2.26 antigen (T1alpha-2, podoplanin), a small membrane mucin induced in oral squamous cell carcinomas. Int J Cancer 113:899\u2013910","journal-title":"Int J Cancer"},{"key":"385_CR34","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ccr.2006.03.010","volume":"9","author":"A Wicki","year":"2006","unstructured":"Wicki A, Lehembre F, Wick N, Hantusch B, Kerjaschki D, Christofori G (2006) Tumor invasion in the absence of epithelial\u2013mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton. Cancer Cell 9:261\u2013272","journal-title":"Cancer Cell"},{"key":"385_CR35","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2133.2005.06558.x","volume":"153","author":"L Valeyrie-Allanore","year":"2005","unstructured":"Valeyrie-Allanore L, Isma\u00efli N, Bastuji-Garin S et al (2005) Symptoms associated with malignancy of peripheral nerve sheath tumours: a retrospective study of 69 patients with neurofibromatosis 1. Br J Dermatol 153:79\u201382","journal-title":"Br J Dermatol"},{"key":"385_CR36","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/j.1365-2133.2008.08494.x","volume":"158","author":"L Valeyrie-Allanore","year":"2008","unstructured":"Valeyrie-Allanore L, Ortonne N, Lantieri L et al (2008) Histopathologically dysplastic neurofibromas in neurofibromatosis 1: diagnostic criteria, prevalence and clinical significance. Br J Dermatol 158:1008\u20131012","journal-title":"Br J Dermatol"},{"key":"385_CR37","first-page":"1819","volume":"27","author":"VF Mautner","year":"2007","unstructured":"Mautner VF, Brenner W, F\u00fcnsterer C, Hagel C, Gawad K, Friedrich RE (2007) Clinical relevance of positron emission tomography and magnetic resonance imaging in the progression of internal plexiform neurofibroma in NF1. Anticancer Res 27:1819\u20131822","journal-title":"Anticancer Res"},{"key":"385_CR38","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s00259-005-0030-1","volume":"33","author":"W Brenner","year":"2006","unstructured":"Brenner W, Friedrich RE, Gawad KA, Hagel C, von Deimling A, de Wit M, Buchert R, Clausen M, Mautner VF (2006) Prognostic relevance of FDG PET in patients with neurofibromatosis type-1 and malignant peripheral nerve sheath tumours. Eur J Nucl Med Mol Imaging 33:428\u2013432","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"385_CR39","first-page":"335","volume":"26","author":"A Hruska","year":"2004","unstructured":"Hruska A, Bollmann R, Kov\u00e1cs RB, Bollmann M, Bod\u00f3 M, S\u00e1pi Z (2004) DNA ploidy and chromosome (FISH) pattern analysis of peripheral nerve sheath tumors. Cell Oncol 26:335\u2013345","journal-title":"Cell Oncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-010-0385-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-010-0385-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-010-0385-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T09:36:11Z","timestamp":1591868171000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-010-0385-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,7]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["385"],"URL":"https:\/\/doi.org\/10.1007\/s11060-010-0385-4","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,7]]}}}